Welcome to Episode 2 of our IVD Series! 🎉

In this episode, we dive into the critical differences between regulatory requirements and reimbursement for In Vitro Diagnostic (IVD) devices.

Joining us is Eric Lam, PhD, Vice President of Market Access and Reimbursement at Avania, who shares his expertise on navigating these complex processes.

Key Highlights:
🔍 Understanding the evidence needed for regulatory approval vs. reimbursement
⏳ Typical timelines for obtaining regulatory approval and securing reimbursement
💡 Strategies for streamlining regulatory and reimbursement requirements
📊 How Avania supports IVD companies with regulatory, reimbursement, and clinical operations

Eric breaks down the nuances of achieving coding, coverage, and payment, highlighting the importance of clinical utility in securing reimbursement. Plus, he shares how Avania’s holistic approach and hands-on expertise make the process more efficient.

Whether you're in the diagnostic industry or curious about the IVD landscape, this episode is packed with valuable insights!

Don’t forget to like, comment, and subscribe for more episodes in the series. 🚀

#IVDSeries #Diagnostics #RegulatoryApproval #Reimbursement #Avania #ClinicalUtility #MarketAccess

свернуть